These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 8091920)

  • 1. The transdermal drug delivery system and transcutaneous absorption.
    Morimoto Y; Sugibayashi K; Natsume H
    Acta Derm Venereol Suppl (Stockh); 1994; 185():15-7. PubMed ID: 8091920
    [No Abstract]   [Full Text] [Related]  

  • 2. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.
    Godin B; Touitou E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1152-61. PubMed ID: 17889400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced transdermal delivery of a dipeptide by dermaportation.
    Namjoshi S; Chen Y; Edwards J; Benson HA
    Biopolymers; 2008; 90(5):655-62. PubMed ID: 18536044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of transdermal penetration enhancers by high-throughput screening.
    Karande P; Jain A; Mitragotri S
    Nat Biotechnol; 2004 Feb; 22(2):192-7. PubMed ID: 14704682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M; Ali A
    Drug Dev Ind Pharm; 2011 May; 37(5):583-96. PubMed ID: 21469947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation.
    Murthy SN; Zhao YL; Sen A; Hui SW
    J Control Release; 2004 Oct; 99(3):393-402. PubMed ID: 15451597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro human topical bioactive drug transdermal absorption: estradiol.
    Xing MM; Hui X; Zhong W; Pan N; Yaghmaie F; Maibach HI
    Cutan Ocul Toxicol; 2009; 28(4):171-5. PubMed ID: 19888886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Percutaneous absorption].
    Lafforgue C; Marty JP
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S18-23. PubMed ID: 17563709
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced skin permeability for transdermal drug delivery: physiopathological and physicochemical considerations.
    Xu P; Chien YW
    Crit Rev Ther Drug Carrier Syst; 1991; 8(3):211-36. PubMed ID: 1954651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualization of skin penetration using confocal laser scanning microscopy.
    Alvarez-Román R; Naik A; Kalia YN; Fessi H; Guy RH
    Eur J Pharm Biopharm; 2004 Sep; 58(2):301-16. PubMed ID: 15296957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breaching the skin's barrier to drugs.
    Barry BW
    Nat Biotechnol; 2004 Feb; 22(2):165-7. PubMed ID: 14755286
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of photo-damaged skin of nano-scale atRA particles using a novel transdermal delivery.
    Yamaguchi Y; Nagasawa T; Nakamura N; Takenaga M; Mizoguchi M; Kawai S; Mizushima Y; Igarashi R
    J Control Release; 2005 May; 104(1):29-40. PubMed ID: 15866332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal drug delivery systems: skin perturbation devices.
    Brown MB; Traynor MJ; Martin GP; Akomeah FK
    Methods Mol Biol; 2008; 437():119-39. PubMed ID: 18369965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural products as potential drug permeation enhancer in transdermal drug delivery system.
    Patil UK; Saraogi R
    Arch Dermatol Res; 2014 Jul; 306(5):419-26. PubMed ID: 24481830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of skin hydration and its barrier function by vehicle and permeation enhancers: a study using TGA, FTIR, TEWL and drug permeation as markers.
    Shah DK; Khandavilli S; Panchagnula R
    Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):499-512. PubMed ID: 18985178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the effect of occlusive dressings on lamellar bodies in the stratum corneum and relevance to transdermal absorption.
    Kennish L; Reidenberg B
    Dermatol Online J; 2005 Dec; 11(3):7. PubMed ID: 16409903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of ethinylestradiol from film forming polymeric solutions across human epidermis in vitro and in vivo in pigs.
    Zurdo Schroeder I; Franke P; Schaefer UF; Lehr CM
    J Control Release; 2007 Apr; 118(2):196-203. PubMed ID: 17289207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.